197 related articles for article (PubMed ID: 9540786)
1. [Problems associated with the use and monitoring of cyclosporin. Experience at a Clinical Pharmacology Service].
Loffreda A; Contaldi C; Santis DD; Marabese I; Chiaiese C; Formato P; Motola G; Russo F; D'Alessio O; Lampa E; Rossi F
Minerva Med; 1997 Dec; 88(12):543-9. PubMed ID: 9540786
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis.
Ieiri I; Nakayama J; Murakami H; Hori Y; Higuchi S
Int J Clin Pharmacol Ther; 1996 Mar; 34(3):106-11. PubMed ID: 8705088
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three methods for cyclosporine therapeutic monitoring.
Jebabli N; Klouz A; Bahlous A; Gaïes E; Trabelsi S; Lakhal M; Belkahia C
Transplant Proc; 2007 Oct; 39(8):2557-9. PubMed ID: 17954172
[TBL] [Abstract][Full Text] [Related]
4. The determination of metabolite M17 and its meaning for immunosuppressive cyclosporin therapy.
Khoschsorur G; Auer T; Lanzer G; Petritsch P; Holzer H; Tscheliessnigg KH
Angiology; 1998 Apr; 49(4):307-14. PubMed ID: 9555934
[TBL] [Abstract][Full Text] [Related]
5. [A new strategy for monitoring levels of cyclosporin A in the blood of patients after kidney transplantation].
Halacová M; Jedlicková B; Průsa R
Ceska Slov Farm; 2003 Nov; 52(6):267-71. PubMed ID: 14661365
[TBL] [Abstract][Full Text] [Related]
6. Evolution of the therapeutic drug monitoring of cyclosporine.
Citterio F
Transplant Proc; 2004 Mar; 36(2 Suppl):420S-425S. PubMed ID: 15041378
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the new heterogeneous ACMIA immunoassay for the determination of whole-blood cyclosporine concentrations in bone marrow, kidney, heart, and liver transplant recipients.
Huet E; Morand K; Blanchet B; Astier A; Hulin A
Transplant Proc; 2004 Jun; 36(5):1317-20. PubMed ID: 15251322
[TBL] [Abstract][Full Text] [Related]
8. [The clinical usefulness of cyclosporine therapeutic monitoring].
Di Fede G; Iacò V; Pepe S; Salerno L
Clin Ter; 1999; 150(5):339-42. PubMed ID: 10687263
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine C2 monitoring improves renal dysfunction after lung transplantation.
Glanville AR; Morton JM; Aboyoun CL; Plit ML; Malouf MA
J Heart Lung Transplant; 2004 Oct; 23(10):1170-4. PubMed ID: 15477111
[TBL] [Abstract][Full Text] [Related]
10. Polyclonal/monoclonal ratio in kidney and bone marrow transplanted patients treated with cyclosporine.
Capone D; De Marino V; Caso N; Stanziale P; Fontana R; Imperatore P; De Marino V; Pisanti N
Clin Transplant; 1998 Oct; 12(5):430-3. PubMed ID: 9787953
[TBL] [Abstract][Full Text] [Related]
11. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients.
Paydaş S; Balal M; Sertdemir Y; Seyrek N; Karayaylali I
Ren Fail; 2005; 27(4):409-13. PubMed ID: 16060128
[TBL] [Abstract][Full Text] [Related]
12. [Determination of cyclosporine A using high-performance liquid chromatography].
Komzáková I; Brozmanová H; Safarcík K; Grundmann M
Ceska Slov Farm; 2002 May; 51(3):107-11. PubMed ID: 12058350
[TBL] [Abstract][Full Text] [Related]
13. Experience with cyclosporine.
Ready A
Transplant Proc; 2004 Mar; 36(2 Suppl):135S-138S. PubMed ID: 15041323
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic whole-blood levels of cyclosporin A in heart and lung transplantation.
Andert SE; Grimm M; Schreiner W; Müller MM
Clin Chim Acta; 1994 Jan; 224(2):159-66. PubMed ID: 8004786
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic follow-up of cyclosporine: specific problems in kidney, liver, bone marrow grafts and in the treatment of autoimmune diseases].
Garraffo R
Therapie; 1992; 47(4):327-34. PubMed ID: 1494797
[TBL] [Abstract][Full Text] [Related]
16. [Monitoring of cyclosporin A concentration in whole blood with fluorescence polarization immunoassay after bone marrow transplantation].
Murayama T; Matsushita K; Takahashi T; Matozaki S; Nakagawa T; Isobe T
Rinsho Ketsueki; 1992 Apr; 33(4):413-7. PubMed ID: 1602602
[TBL] [Abstract][Full Text] [Related]
17. Evaluation and comparison of therapeutic monitoring of whole-blood levels of cyclosporin A and its metabolites in renal transplantation by HPLC and RIA methods.
Safarcík K; Brozmanová H; Bartos V; Jegorov A; Grundmann M
Clin Chim Acta; 2001 Aug; 310(2):165-71. PubMed ID: 11498082
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic monitoring of cyclosporine A].
Komzáková I; Safarcík K; Brozmanová H; Grundmann M
Ceska Slov Farm; 2002 Jul; 51(4):159-67. PubMed ID: 12183901
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0.
Loichot C; Bentue-Ferrer D; Bernard N; Bonardet A; Boulieu R; Kergueris MF; Paintaud G; Peytavin G; Simon N; Marquet P;
Fundam Clin Pharmacol; 2006 Feb; 20(1):91-6. PubMed ID: 16448399
[TBL] [Abstract][Full Text] [Related]
20. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
